• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
WEI Qiangqiang, DUAN Wenhu, ZHOU Jinpei, ZHANG Huibin. Recent research progress in small molecule AMPK direct activators[J]. Journal of China Pharmaceutical University, 2015, 46(4): 406-415. DOI: 10.11665/j.issn.1000-5048.20150404
Citation: WEI Qiangqiang, DUAN Wenhu, ZHOU Jinpei, ZHANG Huibin. Recent research progress in small molecule AMPK direct activators[J]. Journal of China Pharmaceutical University, 2015, 46(4): 406-415. DOI: 10.11665/j.issn.1000-5048.20150404
shu

Recent research progress in small molecule AMPK direct activators

More Information
    Graphical Abstract
    • Abstract
  • Type 2 diabetes, an epidemic disorder characterized by high blood glucose level associated with microvascular complications, is one of the main causes of human suffer across the globe, with no effective medicine up to now. AMP-activated protein kinase(AMPK), a highly conserved serine/threonine protein kinase, is a key sensor and regulator of intracellular and whole-body energy metabolism. Small molecule AMPK direct activators have been proven to lower blood-glucose, which is a promising candidate for the treatment of type 2 diabetes. The progress on the research of small molecule AMPK direct activators in recent years is summarized in this paper.
    • FullText(HTML)
    • References (41)
  • [1]
    Saltiel AR,Kahn CR.Insulin signaling and the regulation of glucose and lipid metabolism[J].Nature,2001,414(6865):799-806.
    [2]
    Nathan DM,Buse JB,Davidson MB,et al.Management of hyperglycemia in type 2 diabetes:a consensus algorithm for the initiation and adjustment of therapy:a consensus statement from the American diabetes association and the European association for the study of diabetes[J].Diabetes Care,2006,29(8):1963-1972.
    [3]
    Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action[J].J Clin Investig,2001,108(8):1167-1174.
    [4]
    Scott JW,Ross FA,Liu JK,et al.Regulation of AMP-activated protein kinase by a pseudosubstrate sequence on the γ subunit[J].EMBO J,2007,26(3):806-815.
    [5]
    Viollet B,Lantier L,Devin-Leclerc J,et al.Targeting the AMPK pathway for the treatment of type 2 diabetes[J].Front Biosci,Landmark Ed.,2009,14(9):3380-3400.
    [6]
    Hardie DG,Hawley SA,Scott JW.AMP-activated protein kinase-development of the energy sensor concept[J].J Physiol,2006,574(Pt 1):7-15.
    [7]
    Rana S,Blowers EC,Natarajan A.Small molecule adenosine 5′-monophosphate activated protein kinase(AMPK)modulators and human diseases[J].J Med Chem,2015,58(1):2-29.
    [8]
    Schimmack G, Defronzo RA, Musi N. AMP-activated protein kinase:role in metabolism and therapeutic implications[J].Diabetes Obes Metab,2006,8(6):591-602.
    [9]
    Xiao B,Sanders MJ,Underwood E,et al.Structure of mammalian AMPK and its regulation by ADP[J].Nature,2011,472(7342):230-243.
    [10]
    Zhang BB,Zhou G,Li C.AMPK:an emerging drug target for diabetes and the metabolic syndrome[J].Cell Metab,2009,9(5):407-416.
    [11]
    Shaw RJ,Kosmatka M,Bardeesy N,et al.The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress[J].Proc Natl Acad Sci U S A,2004,101(10):3329-3335.
    [12]
    Xie M,Zhang D,Dyck JR,et al.A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway[J].Proc Natl Acad Sci U S A,2006,103(46):17378-17383.
    [13]
    Hardie DG.AMP-activated protein kinase as a drug target[J].Annu Rev Pharmacol Toxicol,2007,47:185-210.
    [14]
    Bergeron R,Previs SF,Cline GW,et al.Effect of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese zucker rats[J].Diabetes,2001,50(5):1076-1082.
    [15]
    McGee SL,Hargreaves M.Exercise and skeletal muscle glucose transporter 4 expression:molecular mechanisms[J].Clin Exp Pharmacol Physiol,2006,33(4):395-399.
    [16]
    Foretz M, Ancellin N, Andreelli F, et al. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver[J].Diabetes,2005,54(5):1331-1339.
    [17]
    Kukidome D,Nishikawa T,Sonoda K,et al.Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells[J].Diabetes,2006,55(1):120-127.
    [18]
    Peabody RA,Goldthwait DA,Greenberg GR.The structure of glycinamide ribotide[J].J Biol Chem,1956,221:1071-1081.
    [19]
    Schnebli HP,Hill DL,Bennett LL,Jr.Purification and properties of adenosine kinase from human tumor cells of type HEp No.2[J].J Biol Chem,1967,242(9):1997-2004.
    [20]
    Henin N,Vincent MF,Van den Berghe G.Stimulation of rat liver AMP-activated protein kinase by AMP analogs[J].Biochim Biophys Acta Gen Subj,1996,1290(2):197-203.
    [21]
    Corton JM,Gillespie JG,Hardie DG.Role of the AMP-activated protein kinase in the cellular stress response[J].Curr Biol,1994,4(4):315-324.
    [22]
    Russell RR,Bergeron R,Shulman GI,et al.Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR[J].Am J Physiol,1999,277(Pt.2):H643-H649.
    [23]
    Hayashi T,Hirshman MF,Kurth EJ,et al.Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport[J].Diabetes,1998,47(8):1369-1373.
    [24]
    Cool B,Zinker B,Chiou W,et al.Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome[J].Cell Metab,2006,3(6):403-416.
    [25]
    Goeransson O,McBride A,Hawley SA,et al.Mechanism of action of A-769662,a valuable tool for activation of AMP-activated protein kinase[J].J Biol Chem,2007,282(45):32549-32560.
    [26]
    Xiao B,Sanders MJ,Carmena D,et al.Structural basis of AMPK regulation by small molecule activators[J].Nat Comm,2013,4(4017):1-10.
    [27]
    Mirguet O,Sautet S,Clement CA,et al.Discovery of pyridones as oral AMPK direct activators[J].ACS Med Chem Lett,2013,4(7):632-636.
    [28]
    Bouillot AMJ,Daugan ACM,Lamotte Y,et al.Preparation of 1H-pyrrolo[3,2-d] pyrimidinedione derivatives as activators of AMPK:US,2012119979A1[P].2012-09-13[2015-02-09] .
    [29]
    Bookser BC,Dang Q,Gibson TS,et al.Preparation of cyclic benzimidazole derivatives as activators of AMP-protein kinase useful anti-diabetic agents:US,2010036613A1[P].2010-04-01[2015-02-09] .
    [30]
    Bookser BC, Dang Q, Gibson TS, et al. Cyclic benzimidazole derivatives as AMP-protein kinase activators and their preparation,pharmaceutical compositions and use in the treatment of diseases:US,2010047982A1[P].2010-04-26[2015-02-09] .
    [31]
    Dang Q,Chung DM,Gibson TS,et al.Novel cyclic benzimidazole derivatives as AMP-activated protein kinase activators and anti-diabetic agents and their preparation:US,2010051176A1[P].2010-05-06[2015-02-09].
    [32]
    Dang Q,Chung DM,Gibson TS,et al.Novel cyclic benzimidazole derivatives as AMP-activated protein kinase activators and anti-diabetic agents and their preparation:US,2010051206A1[P].2010-05-06[2015-02-09].
    [33]
    Kojima E,Fujioka M.Benzimidazole or azabenzimidazole derivative having AMPK-activating effect,pharmaceutical composition containing it,and method prevention or treatment of diabetes mellitus:JP,2014069426A1[P].2014-03-15[2015-02-09].
    [34]
    Kojima E,Hinata Y,Tamura Y,et al.Preparation of 5-oxybenzimidazole and 5-oxyazabenzimidazole derivatives as AMPK activators:JP,2014175330A1[P].2014-10-03[2015-02-09].
    [35]
    Kojima E,Tonogaki K,Tanaka N,et al.Azabenzimidazole derivatives having AMPK-activating activity:JP,2013011932A1[P].2013-01-24[2015-02-09].
    [36]
    Tonogaki K,Ino A,Kojima E,et al.Preparation of hetero ring-fused imidazole derivatives as AMPK activators:JP,2012033149A1[P].2012-08-05[2015-02-09].
    [37]
    Bhattacharya SK,Cameron KOK,Dowling MS,et al.Preparation of indole and indazole compounds that activate AMPK:US,2014140704A1[P].2014-09-18[2015-02-09] .
    [38]
    Pang T, Zhang ZS, Gu M, et al. Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells[J].J Biol Chem,2008,283(23):16051-16060.
    [39]
    Yu LF,Li YY,Su MB,et al.Development of novel alkene oxindole derivatives as orally efficacious AMP-activated protein kinase activators[J].ACS Med Chem Lett,2013,4(5):475-480.
    [40]
    Li YY, Yu LF, Zhang LN, et al. Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice[J].Toxicol Appl Pharmacol,2013,273(2):325-334.
    [41]
    Anil TM,Harish C,Lakshmi MN,et al.CNX-012-570,a direct AMPK activator p
    • Related Articles

  • Related Articles

    [1]HOU Kai, TAN Haoyu, LIU Jing, LI Yunman. Advance of novel target strategies participating in myocardial ischemia reperfusion injury[J]. Journal of China Pharmaceutical University, 2022, 53(2): 164-170. DOI: 10.11665/j.issn.1000-5048.20220205
    [2]LI Fang, XIN Junbo, SHI Qin, MAO Chengqiong. Advances in near infrared photoimmunotherapy of tumor[J]. Journal of China Pharmaceutical University, 2020, 51(6): 664-674. DOI: 10.11665/j.issn.1000-5048.20200604
    [3]TANG Keqin, LIN Huaqing, LI Shuhong, DONG Lixin, LU Bohong, JIANG Hong. Advances in tumor targeted nanocrystals[J]. Journal of China Pharmaceutical University, 2020, 51(4): 418-424. DOI: 10.11665/j.issn.1000-5048.20200405
    [4]LIU Zongliang, ZHANG Renmei, MENG Qingguo. Advances of targeting heat shock protein 70 drugs[J]. Journal of China Pharmaceutical University, 2017, 48(4): 416-424. DOI: 10.11665/j.issn.1000-5048.20170405
    [5]YANG Ruocong, DUAN Feipeng, CHAO Jiahong, TIAN Pengpeng, YAN Zhiyong, LI Shaojing. Advances of microRNA activity in innate immunity[J]. Journal of China Pharmaceutical University, 2017, 48(4): 396-406. DOI: 10.11665/j.issn.1000-5048.20170403
    [6]CHEN Ming, XIE Zhouling, LI Tinghan, WEI Zhihui, ZHAO Lu, LI Zhiyu. Advances in research on a novel antitumor target CDK9 and its inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(2): 233-241. DOI: 10.11665/j.issn.1000-5048.20170216
    [7]JIANG Lu, CHEN Dandan, SUN Minjie, PING Qineng, ZHANG Can. Advances of wax matrix tablets[J]. Journal of China Pharmaceutical University, 2016, 47(4): 497-502. DOI: 10.11665/j.issn.1000-5048.20160418
    [8]YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417
    [9]WANG Xinning, XU Bin, ZHOU Jinpei, ZHANG Huibin. Advances of anti-diabetic drugs based on new targets[J]. Journal of China Pharmaceutical University, 2015, 46(2): 141-152. DOI: 10.11665/j.issn.1000-5048.20150202
    [10]WANG Jing, ZHANG Hui-bin, ZHOU Jin-pei, LI Qing. Advances in new anti-tuberculosis targets and related drugs[J]. Journal of China Pharmaceutical University, 2012, 43(1): 1-8.

Catalog

    Get Citation
    PDF
    XML
    Article views (1281) PDF downloads (3707) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：437052

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return